initial public offerings (IPOs) trading on American exchanges

Thursday, October 21, 2021

Ventyx Biosciences (VTYX) began trading on the Nasdaq on Thur 21 Oct 21

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases.
  • Sector(s): Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 44
  • Incorporated in 2018 
  • HQ: Encinitas, California 
Ventyx Biosciences priced upsized 9,472,656 share IPO at $16/share, at the midpoint of the $15-17 expected range
Opened at $18.65 

No comments:

Post a Comment